Methylenedisalicylic acid derivatives: new PTP1B inhibitors that confer resistance to diet-induced obesity

Bioorg Med Chem Lett. 2007 May 15;17(10):2760-4. doi: 10.1016/j.bmcl.2007.02.069. Epub 2007 Mar 3.

Abstract

Methylenedisalicylic acid derivatives were synthesized and their inhibitory activities against protein tyrosine phosphatases (PTPases) examined. Two of the compounds, 8 and 9, showed K(i) values of 9.4 and 6.3microM against PTP1B, 4- and 7-fold lower values compared to those against TC-PTP. They were reversible and slow-binding inhibitors against PTP1B. When compound 8 was fed to a mouse model, the weight gain and adipocyte fat storage induced by a high-fat-diet were significantly suppressed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipocytes / drug effects
  • Adipocytes / physiology
  • Animals
  • Anti-Obesity Agents / chemical synthesis
  • Anti-Obesity Agents / pharmacology
  • Anti-Obesity Agents / therapeutic use*
  • Diet
  • Disease Models, Animal
  • Mice
  • Mice, Inbred C57BL
  • Obesity / prevention & control*
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1
  • Protein Tyrosine Phosphatases / antagonists & inhibitors*
  • Salicylates / chemical synthesis
  • Salicylates / pharmacology
  • Salicylates / therapeutic use*
  • Weight Gain / drug effects

Substances

  • Anti-Obesity Agents
  • Salicylates
  • 5,5'-methylenedisalicylic acid
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1
  • Protein Tyrosine Phosphatases
  • Ptpn1 protein, mouse